LRRC21 Antibodies

Santa Cruz Biotechnology offers a broad range of LRRC21 monoclonal antibodies for advanced research in cellular biology. LRRC21 monoclonal antibodies are compatible with multiple research applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). LRRC21, or Leucine-Rich Repeat Containing 21, plays a crucial role in cellular signaling and protein interactions, contributing to processes such as cell adhesion and communication. Understanding LRRC21 function is essential for elucidating its involvement in various physiological and pathological conditions, including cancer and neurodegenerative diseases. The study of LRRC21 can provide insights into potential therapeutic targets and biomarkers for disease progression. Researchers worldwide rely on LRRC21 monoclonal antibodies to advance their understanding of cellular mechanisms and pathways. LRRC21 monoclonal antibodies enable precise detection and analysis of protein expression patterns across different cell types and tissues. Santa Cruz Biotechnology monoclonal antibodies support researchers in making meaningful discoveries that contribute to the advancement of scientific knowledge and therapeutic development.